Diagnostic screening of mitochondrial DNA mutations in Australian adults 1990-2001

Internal Medicine Journal

Volumn 34, Issue 1-2, 2004, Pages 10-19

  Marotta, R ^a,b   Chin, J ^a   Quigley, A ^a   Katsabanis, S ^a   Kapsa, R ^a   Byrne, E ^a   Collins, S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Genome; Mitochondria; Mutation; Polymerase chain reaction; Restriction fragment length polymorphism

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOOD ANALYSIS; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE DELETION; GENE REARRANGEMENT; HAIR; HAIR ANALYSIS; HUMAN; HUMAN TISSUE; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; MAJOR CLINICAL STUDY; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL DNA DISORDER; MUSCLE BIOPSY; NARP SYNDROME; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SKELETAL MUSCLE; SOUTHERN BLOTTING; STATISTICAL ANALYSIS;

ADULT; AUSTRALIA; BLOTTING, SOUTHERN; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES; MUTATION; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE ANALYSIS, DNA;

EID: 1442335473     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1444-0903.2004.t01-3-.x     Document Type: Article

References (37)

1. Stryer L. Eucaryotic chromosomes and gene expression. In: Stryer L, ed. Biochemistry, 3rd edn. New York: W H Freeman and Company; 1988; 823-50.
2. Nass S, Nass MMK. Intramitochondrial fibres with DNA characteristics. I. Fixation and electron staining reactions. J Cell Biol 1963; 19: 593-612.
3. Nass S, Nass MMK. Intramitochondrial fibres with DNA characteristics. II. Enzymatic and other hydrolytic treatments. J Cell Biol 1963; 19: 613-29.
4. Nass MMK. The circularity of mitochondrial DNA. Proc Natl Acad Sci USA 1966; 56: 1215-22.
5. Van Bruggen EFJ, Borst P, Ruttenburg GJCM, Gruber M, Kroon AM. Circular mitochondrial DNA. Biochem Biophys Acta 1963; 119: 437-9.
6. Anderson S, Bankier AT, Barrell BG, de Bruijn MHL, Coulson AR, Drouin J et al. Sequence and organization of the human mitochondrial genome. Nature 1981; 290: 457-65.
7. Giles RE, Blanc H, Cann H, Wallace DC. Maternal inheritance of human mitochondrial DNA. Proc Natl Acad Sci USA 1980; 77: 6715-19.
8. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-19.
9. Wallace DC, Singh G, Lott M, Hodge JA, Schurr TG, Lezza AM et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988; 242: 1427-30.
10. Fukuhara N, Tokiguchi S, Shirakawa K, Tsubaki T. Myoclonus epilepsy associated with ragged-red fibres (mitochondrial abnormalities): disease or a syndrome? Light and electron-microscopic studies of two cases and a review of the literature. J Neurol Sci 1980; 47: 117-33.
11. Rosing HS, Hopkins LC, Wallace DC, Epstein CM, Weidenheim K. Maternally inherited mitochondrial myopathy and myoclonic epilepsy. Ann Neurol 1985; 17: 228-37.
12. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.
13. Shoffner JM, Lott MT, Lezza AMS, Seibel P, Ballinger SW, Wallace DC. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNALys mutation. Cell 1990; 61: 931-7.
14. (Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
15. Kogelnik AM, Lott MT, Brown MD, Navathe SB, Wallace DC. MITOMAP: human mitochondrial genome database - 1998 update. Nucleic Acids Res 1998; 26: 112-15.
16. Holt IJ, Harding AE, Morgan-Hughes JA. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-19.
17. Byrne E. Mitochondrial DNA abnormalities in human disease. Med J Aust 1991; 154: 646-7.
18. Shoffner JM, Wallace DC. Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, Vol. 1, 7th edn. New York: McGraw-Hill; 1995; 1535-1609.
19. Kotsimbos N, Jean-Francois MJB, Huizing M, Kapsa RMI, Lertrit P, Siregar NC et al. Rapid and non-invasive screening of patients with mitochondrial myopathy. Hum Mutat 1994; 4: 132-5.
20. Vikki J, Savontaus ML, Nikoskelainen EK. Human mitochondrial DNA types in Finland. Hum Genet 1988; 80: 317-21.
21. Howell N, Miller NR, Mackey DA, Arnold A, Hernstadt C, Williams IM et al. Lighting strikes twice: Leber's hereditary optic neuropathy families with two pathogenic mtDNA mutations. J Neuroophthalmol 2002; 22: 262-9.
22. Lamont PJ, Surtees R, Woodward CE, Leonard JV, Wood NW, Harding AE. Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child 1998; 79: 22-7.
23. Blumethal DT, Shanske S, Schochet SS, Santorelli FM, Di Mauro S, Jaynesm M et al. Myoclonus epilepsy with ragged red fibres and multiple mtDNA deletions. Neurology 1998; 50: 524-5.
24. Sternberg D, Chatzoglou E, Laforet P, Fayet G, Jardel C, Blondy P et al. Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Brain 2001; 124: 984-94.
25. Chinnery PF, Brown DT, Andrews RM, Singh-Kler R, Riordan-Eva P, Lindley J et al. The mitochondrial ND6 gene is a hot spot for mutations that cause Leber's hereditary optic neuropathy. Brain 2001; 124: 209-13.
26. Sue CM, Quigley A, Katsabanis S, Kapsa R, Crimmins DS, Byrne E et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neurol Sci 1998; 161: 36-9.
27. McKelvie PA, Morely JB, Byrne E, Marzuki S. Mitochondrial encephlomyopathies: correlation between neuropathological findings and defects in mitochondrial DNA. J Neurol Sci 1991; 102: 51-60.
28. Lertrit P, Noer AS, Byrne E, Marzuki S. Tissue segregation of a heteroplasmic mtDNA in MERRF (myoclonic epilepsy with ragged red fibres) encephalomyopathy. Hum Genet 1992; 90: 251-4.
29. Quigley A, Reardon K, Kapsa R, Dennett X, Byrne E, Thyagarajan D. A novel clinical phenotype of myopathy, sensorimotor neuropathy, infertility, and hypogonadism with multiple mitochondrial DNA deletions. J Clin Neuromus Dis 2001; 3: 77-82.
30. Lewis S, Hutchinson W, Thyagarajan D, Dahl HM. Clinical features of adPEO due to mutations in the Twinkle gene. J Neurol Sci 2002; 201: 39.
31. Naviaux RK. The spectrum of mitochondrial disease. A primary care physician's guide. Exceptional parents magazines [online publication, cited April 1999] Available from: URL: http://biochemgen.ucsd.edu/mmdc/ep-3-10.pdf
32. Chinnery PF, Johnson MA, Wardell TM, Singh-Kler R, Hayes C, Brown DT et al. The epidemiology of pathogenic mitochondrial mutations. Ann Neurol 2000; 48: 188-93.
33. Brown MD, Allen JC, Van Stavern GP, Newman NJ, Wallace D. Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations. Am J Hum Genet 2001; 104: 331-8.
34. Chinnery PF, Howell N, Lightowlers RN, Turnbull DM. MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring. Brain 1998; 121: 1889-94.
35. Di Mauro S, Moraes T. Mitochondrial encephalomyopathies. Arch Neurol 1993; 50: 1197-1208.
36. Di Mauro S. Mitochondrial myopathy. In: Feldmann E, ed. Current Diagnosis in Neurology. St Louis: Mosby-Year Book; 1994; 340-45.
37. Schmiedel J, Jackson S, Schäfer J, Reichman H. Mitochondrial cytopathies. J Neurol 2003; 250: 267-77.